In the COMPASS trial of patients with stable coronary or peripheral artery disease (PAD), the combination of aspirin plus rivaroxaban, 2.5 mg twice daily, provided a larger absolute benefit on ...

EVERETT, Wash.--(BUSINESS WIRE)--Compass Health’s Building Communities of Hope Gala raised more than $165,000 in support of the organization’s child, youth and family behavioral health services during ...

Among patients with stable CAD or PAD, those with diabetes appear to derive greater absolute benefits from a combination of low-dose rivaroxaban (Xarelto; Bayer/Janssen) and aspirin compared with ...

EVERETT, Wash., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Compass Health, Northwest Washington’s behavioral healthcare leader, has launched a new recruitment initiative aimed at attracting skilled ...